Tag: alli

FDA Approves New Kidney Risk Warnings for OTC Weight Loss Drug alli

10 Jun 2026 1:18 p.m. · Source: US Food and Drug Administration

The FDA has approved new labeling for the OTC weight loss drug alli (orlistat) 60 mg, warning of rare risks including acute kidney injury and kidney stones. Consumers with a history of kidney issues should consult a doctor before use.

Health Politics and Government Medical Science Federal Government Education FDA alli orlistat kidney injury kidney stones weight loss Drug Safety Food Recalls Drugs